Related Experiment Video
Updated: Nov 15, 2025
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
4.7K
Technology Use and Preferences for Minority Diabetes Self-Management Application.
Journal of Health Care for the Poor and Underserved
|March 8, 2021
Summary
Minority patients with diabetes desire mobile apps for self-management, including health data and food suggestions. Future apps should consider these preferences for better engagement.
Area of Science:
- Diabetes self-management technology
- Health informatics
- Minority health
Background:
- Effective diabetes self-management is crucial for patient outcomes.
- Mobile health applications offer potential for improved diabetes care.
- Understanding technology preferences among minority populations is key for app design.
Purpose of the Study:
- To explore technology use and preferences of minority patients with diabetes.
- To inform the design of a mobile/online health application for diabetes self-management.
Main Methods:
- Focus groups were conducted with minority patients diagnosed with diabetes.
- Qualitative data on technology use and preferences were collected.
Main Results:
- Participants expressed a need for mobile/online applications to aid diabetes self-management.
- Key features desired in self-management apps include health-related data tracking and dietary suggestions.
- Preferences varied, highlighting the need for user-centered design.
Conclusions:
- Mobile/online health applications can support diabetes self-management in minority populations.
- Future app development should incorporate user-identified features like data tracking and food guidance.
- Further research is recommended to optimize digital health tools for diverse patient groups.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
694
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
694
01:22Diabetes Mellitus: Overview and Type I Subtype
4.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.2K
01:22Diabetes Mellitus: Type 2 and Gestational
3.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
01:15Diabetes: Symptoms, Diagnosis, and Complications
1.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.5K
01:29Issues And Trends In Healthcare Delivery System
6.0K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.0K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
432
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
432